Experience

• 

  Molycorp, inc.

  May 1998 - Sept 1998

  Quality control technician

  Prepare powder pellets and glass beads of raw materials and metal products Run qualitative and quantitative analysis using XRF with Phillips PW1400 Spectrometer Update Molybdenum and other products/chemicals MSDS binders Run Carbon, Sulfur, Nitrogen, and Oxygen analysis on LECO Analyzers

• 

  Procter & gamble

  Jun 2002 - Aug 2002

  Ph.d intern

  Develop model experiments for upstream research on hair bleaching and dyeing products Measure observed reaction rates using UV/visible spectroscopy for the solution bleaching of different melanin pigment substrates with hydrogen peroxide Collect color values from solution melanin bleaching to correlate trends between the bleaching of solution melanin and bleaching hair switches Establish Standard Operating Procedures for collecting color values on ground hair bleached in solution Study the innate differences in the melanin pigment between red, brown, black, and blonde hair Show less

• 

  Pfizer

  Jun 2004 - May 2016

  Manage product design innovation groupCollaborate directly with Commercial Innovation Lead to development product platforms and road maps for 5-10 new discovery initiatives and launches for US and Global regions annuallyDevelop US and Global Brand strategies for Robitussin, Advil Congestion Relief, and Pediatric Brands with key cross-functional commercial colleaguesLead R&D sub-team for Rx to OTC switch development to maintain clinical supplies and prepare for multi-national product launch.Manage $4 Million Annual Departmental BudgetLead design team communication huddles to maximize resource allocation and maintain prioritiesMentor junior scientists, interns, and contractors in product design process and formulationsDevelop cross-functional workshop with external vendor on influencing stakeholders to build stronger collaborations and establish new tool kits for team effectiveness.Maintained Principal Scientist role job functions (Shown Below) Show less • Formulate and scale-up of soft gelatin capsules, liquids, and semi-solid OTC consumer drug products for expedited launch timelines.• Launched 2 – ChapStick products, 8 – Robitussin Syrup products, 3 – Robitussin Softgel products, 1 – Preparation H product to date• Develop soft gelatin capsule product through clinical study execution to support dossier generation for new NDA-submission to FDA.• Work with regulatory, CMC, and technical colleagues to facilitate the writing, review and submission of registration dossier to ex-US governmental BOH in EU/EMEA for product approval. • Build interfaces between key R&D colleagues and 3rd Party contract facilities to maintain communication• Work with CMC colleagues to complete, review, and publish IND submissions for FDA review• Lead cross-functional project teams to maintain communication and expedite project timelines• Develop, coordinate, and execute consumer product research focus groups• Direct and coordinate product manufacturing scale-up from lab bench to GMP production facility• Collaborate with scientists in cGMP analytical testing laboratory concerning HPLC/GC assays, stability studies, and development projects to achieve strict launch timelines• Solve experimental obstacles during all aspects of product development• Review and approve data for release of prototypes, stability samples, and clinical release materials Show less

  • Sr. Manager Cough & Personal Care Design Team

    Oct 2013 - May 2016

  • Principal Scientist

    Aug 2012 - Oct 2013

  • Senior R&D Scientist

    Dec 2007 - Aug 2012

  • R&D Scientist

    Jun 2004 - Dec 2007
• 

  John tyler community college

  Jan 2012 - Dec 2013

  Adjunct professor

  • Write and conduct General Chemistry lectures for pre-nursing program and general education students• Facilitate and oversee general chemistry laboratory• Write and grade all quizzes, examinations, and laboratory reports• Conduct additional tutorial sessions and problem solving sessions before examinations and laboratories

• 

  Gsk

  May 2016 - Feb 2022

  Performance and Innovation responsibilities for the Global Respiratory & Skin Health Category with a focus on Global Brands - Theraflu Multi-Symptom, Otrivin Decongestant, Flonase Allergy, and Abreva/Zovirax/Fenistil/Lamisil Establishment of the Respiratory & Skin Health Category with the Pfizer Joint Venture including organizational design, recruitment, operations, communications and culture Lead global cross-functional matrix R&D team (80+ colleagues) to deliver sustaining & disruptive innovation pipeline and business continuity with data-driven prioritization through internal developments and external (open innovation) partnerships.Recruit and develop, virtually during COVID pandemic, strong, accountable development team (15 colleagues) as part of the new US R&D Center of Excellence, including the creation of a world-leading nasal spray characterization capability.Delivered consumer-relevant global innovation, sustainability, and growth strategy for £1.2 Billion Category in partnership w/Commercial Category General Manager.Increased incremental innovation pipeline sales ratio from 8% to +13% (+£200M growth) through Medicated / Medical Devices / Naturals / Supplements / Cosmetic products.Implement Innovation Funnel vs. Tunnel WoW to successfully increase pipeline from 25 to 35+ projects and early-stage scientific initiatives while scrubbing annual budget from £18M down to £12M.Nyon Campus R&D Lead driving engagement and collaboration at all levels across the site to build R&D pride and drive empowerment with accountability for Environmental Health, Safety & Sustainability, Pandemic Crisis Management, Tier 2 Quality Council, Site Engagement and Inclusion & Diversity, delivering a 20% improvement in engagement for 120+ colleagues.Defended portfolio ingredient risks (Paracetamol, Nicotine, TiO2, Nitrosamines) through scientifically grounded positions to Health Authorities, pro-active remediation programs, and continuous external monitoring. Show less Led global cross-functional matrix R&D team across Switzerland, India, and China (35+ colleagues) to deliver global-scale innovations for Otrivin Brand.Delivered consumer-driven innovation pipeline strategy for global £275 Million Category with Global Commercial Brand Lead.Increased innovation pipeline sales ratio from 9 - 15% (£40M growth) through Medicated/Medical Device products.Established world-leading nasal spray characterization laboratory capability in India to increase development efficiency and decrease external vendor reliance and cost.Delivered new nasal spray pump technology to improve experience, sustainability, and cost of goods.Established Nyon R&D Leadership team to deliver scientific capability learning, Category collaborations, culture immersion, and development opportunitiesCreated a semi-independent entity (www.thecleanbreathinginstitute.com) with a mission to compete against the breathing effects of air aggressors on consumers through education, partnership, research, and innovation to drive expert recommendations and Otrivin brand penetration. Show less

  • Vice President, Respiratory & Skin Health Category R&D

    Jan 2019 - Feb 2022

  • Senior Director & R&D Lead - Nasal Health Category

    Jul 2017 - Apr 2019

  • Senior Director & R&D Lead - Allergy Category

    May 2016 - Jul 2017
• 

  Johnson & johnson consumer health

  Feb 2022 - May 2023

  • Vice President, Head of EMEA R&D

    Mar 2023 - May 2023

  • EMEA R&D Head of Essential Health & Skin Health Franchises

    Feb 2022 - Mar 2023
• 

  Kenvue

  May 2023 - now

  Vice president, head of emea r&d